Bio-Techne Financials - Benzinga

Bio-Techne Corp

TECHNASDAQ

Trade with Public

Trade with Public

$72.54

0.020.03%

最終更新: Sep 24, 11:50 AM

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Bio-Techne Financials

Bio-Techne (TECH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Bio-Techne Q3 Adj. EPS $0.53 Misses $0.54 Estimate, Sales $311.415M Miss $317.093M Estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.54 by 1.85 percent. This is a 5.36 percent decrease over earnings of $0.56 per share from the same

Benzinga Newsdesk

Insights into Bio-Techne Q2 Earnings

Benzinga Insights

Bio-Techne Earnings Review: Q2 Summary

Benzinga Insights

Earnings Breakdown: Bio-Techne Q2

Benzinga Insights

© 2026 Benzinga | All Rights Reserved